350 related articles for article (PubMed ID: 22240117)
1. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.
Choi HK; Soriano LC; Zhang Y; Rodríguez LA
BMJ; 2012 Jan; 344():d8190. PubMed ID: 22240117
[TBL] [Abstract][Full Text] [Related]
2. Use of diuretics and risk of incident gout: a population-based case-control study.
Bruderer S; Bodmer M; Jick SS; Meier CR
Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.
Bhaskaran K; Douglas I; Evans S; van Staa T; Smeeth L
BMJ; 2012 Apr; 344():e2697. PubMed ID: 22531797
[TBL] [Abstract][Full Text] [Related]
5. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
6. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of angiotensin receptor blockers and the risk of cancer.
Azoulay L; Assimes TL; Yin H; Bartels DB; Schiffrin EL; Suissa S
PLoS One; 2012; 7(12):e50893. PubMed ID: 23251399
[TBL] [Abstract][Full Text] [Related]
9. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.
Lapi F; Azoulay L; Yin H; Nessim SJ; Suissa S
BMJ; 2013 Jan; 346():e8525. PubMed ID: 23299844
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drugs and the risk of incident rosacea.
Spoendlin J; Voegel JJ; Jick SS; Meier CR
Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
[TBL] [Abstract][Full Text] [Related]
11. Effects of antihypertensive treatments on incidence of diabetes: a case-control study.
Monami M; Ungar A; Lamanna C; Bardini G; Pala L; Dicembrini I; Marchi C; Vivarelli M; Zannoni S; Bartoli N; Marchionni N; Rotella CM; Mannucci E
J Endocrinol Invest; 2012 Feb; 35(2):135-8. PubMed ID: 21613812
[TBL] [Abstract][Full Text] [Related]
12. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
13. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1129-1138. PubMed ID: 32675281
[TBL] [Abstract][Full Text] [Related]
14. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
15. Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.
Dial S; Nessim SJ; Kezouh A; Benisty J; Suissa S
Br J Clin Pharmacol; 2014 Nov; 78(5):1151-8. PubMed ID: 24803383
[TBL] [Abstract][Full Text] [Related]
16. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
19. Prescribing cascades of antigout medications from thiazide diuretics in gout-naïve hypertensive adults receiving first-line pharmacological management.
Lu SY; Hsu HY; Hsieh YW; Lu CR; Huang HY; Chang SS
Sci Rep; 2024 Mar; 14(1):7402. PubMed ID: 38548957
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of antihypertensive drugs in a community-based setting.
Grégoire JP; Moisan J; Guibert R; Ciampi A; Milot A; Côté I; Gaudet M
Clin Ther; 2001 May; 23(5):715-26. PubMed ID: 11394730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
